Author Archives: Marta Figueiredo

Darzalex Triple Combo Approved in Europe for Myeloma Patients Ineligible for ASCT

The European Commission has approved Darzalex (daratumumab), in combination with Revlimid (lenalidomide) and dexamethasone, as a first-line treatment for adults with multiple myeloma who are ineligible for autologous stem cell transplant (ASCT). The decision was supported by the recent approval recommendation from the Committee for Medicinal Products for Human Use, an…